portfolio as of Q2 2026, filed Aug 14, 2026
Latest 13F filing: Q2 2026 (filed Aug 14, 2026). No newer filing yet.
3 of 11 holdings are Undervalued or On Sale by our valuation (19% of the money).
Valued by PaybackPrice; holdings from SEC 13F filings as of Jun 30, 2026. 7 not valued.
ValueAct Capital's portfolio holds 18 stocks worth $5.6B at the end of Q2 2026. The largest positions are V, AMZN, RKT, BLK and META.
In Q2 2026, ValueAct Capital opened 1 new position (PAYP) and added to CBRE, RKT and SPOT.
In Q2 2026, ValueAct Capital sold out of DIS and trimmed LLYVA, LLYVK, LYV, MDB, RBLX and SSD.
CRM, RBLX and WIX are Undervalued or On Sale by our valuation.
Latest 13F filing: Q2 2026 (filed Aug 14, 2026). No newer filing yet.
From SEC Form 13F-HR — up to 45 days old at time of filing. Not a recommendation to buy or sell. Analyze any of these free →